Children who received SQ-LNSs had significantly higher Hb concentrations (2.77 g/L) relative to the control, and SQ-LNSs reduced the prevalence of anemia and moderate-to-severe anemia by 16% (10 percentage points) and 28% (7 percentage points), respectively. The gene discussed is GSTM1; the disease is anemia (phenotype).